Molina Healthcare, INC Form 4 insider transactions

NYSE
Molina Healthcare's Chief Legal Officer, Jeff D. Barlow, acquired 85 shares of common stock at $247.39 per share through the company's Employee Stock Purchase Plan, increasing his total beneficial ownership to 72,902 shares.
NYSE
Director Dale B. Wolf sold 1,500 shares of Molina Healthcare (MOH) common stock held by his revocable trust on May 21, 2025, at prices ranging from $320.51 to $324.42.
NYSE
Steven J. Orlando, a director at Molina Healthcare, filed an amended Form 4 (Form 4/A) to correct an omission of 1,500 shares held in his 401(k) from the original filing on May 5, 2025.
NYSE
Director Steven Orlando sold 1,000 shares of Molina Healthcare (MOH) common stock at an average price of $318.58 on May 5, 2025.
NYSE
Director Leo Grohowski reports acquiring 118 shares of Molina Healthcare common stock under the company's 2025 Incentive Plan.
NYSE
Molina Healthcare's CEO, Joseph M. Zubretsky, executed transactions involving the company's common stock, including sales and a trust transfer, as detailed in a recent SEC filing.
NYSE
Director Richard M. Schapiro sold 669 shares of Molina Healthcare, Inc. at an average price of $320.50 on April 29, 2025.
NYSE
Director Richard C. Zoretic acquired 168 shares of Molina Healthcare, Inc. common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Dale B. Wolf acquired 168 shares of Molina Healthcare common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Richard M. Schapiro acquired 168 shares of Molina Healthcare common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Ronna Romney acquired 168 shares of Molina Healthcare common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Steven J. Orlando acquired 168 shares of Molina Healthcare, Inc. common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Stephen H. Lockhart acquired 168 shares of Molina Healthcare common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Daniel Cooperman acquired 56 shares of Molina Healthcare, Inc. common stock on April 1, 2025, as part of the company's equity incentive plan.
NYSE
Director Barbara Brasier reports acquisition of 168 shares of Molina Healthcare common stock as part of the company's equity incentive plan.
NYSE
Jeff D. Barlow, Chief Legal Officer of Molina Healthcare, reports acquisition and disposal of company stock related to performance stock units and restricted stock grants.
NYSE
EVP Debra Bacon reports acquisition and disposal of Molina Healthcare stock related to performance stock units and restricted stock grants.
NYSE
Maurice Hebert, Chief Accounting Officer of Molina Healthcare, reports acquisition and disposal of common stock related to performance stock units and restricted stock grants.
NYSE
James Woys, Chief Operating Officer of Molina Healthcare, reports acquisition and disposal of company stock related to performance stock units and restricted stock grants.
NYSE
Molina Healthcare's CEO, Joseph Zubretsky, reports acquisition and disposal of company stock related to performance stock units and restricted stock grants.
NYSE
Molina Healthcare's CFO, Mark Keim, reports acquisition and disposal of company stock, including shares from performance stock units and restricted stock grants.
NYSE
Director Steven Orlando reported selling 1,000 shares of Molina Healthcare (MOH) common stock at an average price of $301.33 on March 3, 2025.
NYSE
EVP Debra Bacon reports stock acquisition through the Employee Stock Purchase Plan and shares withheld for tax obligations.
NYSE
Director Stephen H. Lockhart acquired 189 shares of Molina Healthcare common stock on January 1, 2025, as part of the company's equity incentive plan.
NYSE
Director Dale B. Wolf reports the acquisition of 189 shares of Molina Healthcare common stock as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Steven Orlando reports the acquisition of 189 shares of Molina Healthcare common stock on January 1, 2025, as part of the company's equity incentive plan.
NYSE
Director Ronna Romney acquired 189 shares of Molina Healthcare, Inc. common stock on January 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Richard C. Zoretic acquired 189 shares of Molina Healthcare, Inc. common stock on January 1, 2025, as part of the company's 2019 Equity Incentive Plan.
NYSE
Director Richard M. Schapiro acquired 189 shares of Molina Healthcare common stock on January 1, 2025, as part of the company's equity incentive plan.
NYSE
Director Barbara Brasier received 189 shares of Molina Healthcare stock as part of her quarterly equity compensation.